Abdominal Adiposity as a Key Metabolic Driver of Fatty Liver in Transition Dairy Cows

The transition period, spanning 21 days before to 21 days after parturition, is characterized by profound metabolic, endocrine, immune, and digestive adaptations required to support lactation. During this period, fatty liver has traditionally been considered a primary hepatic disorder. However, growing evidence indicates that fatty liver is better understood as a systemic metabolic condition driven largely by adipose tissue dynamics, particularly the distribution and activity of abdominal fat. This shift in perspective has major implications for disease prediction, prevention, and long-term herd health management^1,2. 

Negative Energy Balance and Adipose Tissue Mobilization 

The onset of lactation is associated with a sharp increase in energy demand concurrent with a decline in dry matter intake (DMI), resulting in postpartum negative energy balance (NEB). This metabolic state is driven by hypoglycemia caused by glucose diversion toward lactose synthesis and is regulated by hormonal changes, including increased growth hormone and glucagon, reduced insulin, and activation of catecholamines. These signals stimulate hormone-sensitive lipase activity in adipose tissue, triggering triglyceride (TG) breakdown and the release of non-esterified fatty acids (NEFA) into circulation¹. 

When NEFA delivery to the liver exceeds hepatic oxidative and export capacity, excess fatty acids are re-esterified into TG. Because very low-density lipoprotein (VLDL) export is limited in cattle, TG accumulates in hepatocytes, leading to fatty liver^3,4. This process is markedly amplified in cows with excessive adipose reserves. 

Why Abdominal Fat Matters More Than Subcutaneous Fat 

Not all adipose tissue behaves similarly. Abdominal adipose tissue is more lipolytically active and metabolically dynamic than subcutaneous fat. It exhibits higher expression of hormone-sensitive lipase and responds more rapidly to lipolytic stimuli, resulting in greater NEFA release during NEB^1,2. Moreover, the fatty acid profile of abdominal fat closely resembles circulating NEFA, supporting the concept of preferential mobilization from this depot¹. 

Excess abdominal fat is consistently associated with higher circulating NEFA concentrations, particularly under conditions of low insulin, which commonly occur around parturition¹. As a result, cows with greater abdominal adiposity experience more intense fat mobilization, placing a disproportionate metabolic burden on the liver and increasing the risk of fatty liver, ketosis, and displaced abomasum (DA). 

Genetic Control of Fat Distribution and Disease Risk 

Abdominal adiposity is not merely a consequence of nutrition or management; it has a significant genetic component. Studies have identified multiple quantitative trait loci (QTLs) associated with excessive abdominal fat deposition, particularly on bovine chromosomes 12, 19, and 20^5,6. These same genomic regions are also linked to ketosis and DA, indicating pleiotropic genetic control of fat distribution and metabolic disease susceptibility^7,8. 

Importantly, extreme abdominal fat accumulation has been shown to be moderately heritable, even in cows with mild to normal body condition scores (BCS), suggesting that BCS alone is insufficient to assess metabolic risk⁵. These findings explain why cows with similar BCS may exhibit markedly different metabolic outcomes during the transition period. 

Inflammatory and Endocrine Consequences of Abdominal Adiposity 

Abdominal adipose tissue is metabolically active and immunologically responsive. Excess visceral fat is associated with increased macrophage infiltration and elevated expression of pro-inflammatory cytokines, promoting systemic inflammation and insulin resistance^1,2. In high-BCS cows, pro-inflammatory cytokines such as interleukin-1β and interleukin-6 are upregulated predominantly in abdominal fat depots¹. 

Additionally, adiponectin, an adipokine involved in glucose and lipid metabolism, is expressed at much lower levels in abdominal fat compared with subcutaneous fat. Because adiponectin concentrations are inversely related to circulating NEFA, reduced expression in abdominal fat further disrupts metabolic regulation during the transition period. These inflammatory and endocrine alterations intensify lipolysis and exacerbate hepatic TG accumulation¹. 

Interaction Between Diet, Genetics, and Fat Deposition 

Although genetics play a major role, fat distribution is also influenced by feeding systems. Concentrate-based diets promote greater mesenteric and omental fat accumulation compared with silage-based systems, demonstrating that abdominal adiposity reflects an interaction between genetic predisposition and management practices ¹. This reinforces the need to consider both inherited traits and environmental influences when evaluating metabolic risk. 

Clinical Relevance for Veterinary Practice 

Understanding the role of abdominal adiposity provides veterinarians with a more accurate framework for assessing transition cow risk. Reliance on BCS alone may underestimate susceptibility to fatty liver and related disorders. Recognizing abdominal fat as a key regulator of NEFA mobilization, inflammation, and hepatic lipid overload allows for earlier identification of high-risk cows and more informed recommendations regarding feeding strategies, cow comfort, and genetic selection^2,5,6. 

Conclusion 

Abdominal adiposity is a central driver of fatty liver pathophysiology in modern dairy cows. Its heightened lipolytic activity, inflammatory potential, and genetic control explain the increasing severity and prevalence of fatty liver observed in high-producing herds. Reframing fatty liver as a systemic, adipose-driven disorder, rather than a purely hepatic condition, marks a critical step toward improving transition cow health and metabolic resilience. 

References 

1. Melendez P, Pinedo P. Update on fatty liver in dairy cattle with major emphasis on epidemiological patterns, pathophysiology in relationship to abdominal adiposity, and early diagnosis. Dairy. 2024 Oct 31;5(4):672-87. https://doi.org/10.3390/dairy5040050 

2. Contreras GA, Strieder-Barboza C, De Koster J. Symposium review: Modulating adipose tissue lipolysis and remodeling to improve immune function during the transition period and early lactation of dairy cows. Journal of Dairy Science. 2018 Mar 1;101(3):2737-52. https://www.sciencedirect.com/science/article/pii/S0022030217309591 

3. White, H.M. ADSA Foundation Scholar Award: Influencing hepatic metabolism: Can nutrient partitioning be modulated to optimize metabolic health in the transition dairy cow? J. Dairy Sci. 2020, 103, 6741–6750. https://www.sciencedirect.com/science/article/pii/S0022030220304331 

4. Zhou, S.; Chen, M.; Meng, M.; Li, Z.; Chang, G. Subclinical ketosis leads to lipid metabolism disorder by downregulating the expression of acetyl-coenzyme A acetyl-transferase 2 in dairy cows. J. Dairy Sci. 2023, 106, 9892–9909.  https://www.sciencedirect.com/science/article/pii/S0022030223006306 

5. Melendez P, Poock SE, Pithua P, Pinedo P, Manriquez D, Moore SG, Neal JD, Taylor JF. Genome-wide study to detect single nucleotide polymorphisms associated with visceral and subcutaneous fat deposition in Holstein dairy cows. Animal. 2019 Mar;13(3):487-94. https://www.sciencedirect.com/science/article/pii/S1751731118001519 

6. Novo LC, Cavani L, Pinedo P, Melendez P, Peñagaricano F. Genomic analysis of visceral fat accumulation in Holstein cows. Frontiers in Genetics. 2022 Jan 4;12:803216. https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2021.803216/full 

7. McNeel, A.K.; Reiter, B.C.; Weigel, D.; Osterstock, J.; Di Croce, F.A. Validation of genomic predictions for wellness traits in US Holstein cows. J. Dairy Sci. 2017, 100, 9115–9124. https://www.sciencedirect.com/science/article/pii/S0022030217307944 

8. Novo, L.C.; Cavani, L.; Pinedo, P.; Melendez, P.; Penagaricano, F. Genomic Analysis of Visceral Fat Accumulation in Holstein Cows. Front. Genet. 2022, 12, 803216.  https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2021.803216/full